Financials data is unavailable for this security.
View more
Year on year Henan Taloph Pharmaceutical Stock Co Ltd grew revenues 5.57% from 1.96bn to 2.07bn while net income improved from a loss of 72.20m to a gain of 43.56m.
Gross margin | 28.52% |
---|---|
Net profit margin | 5.68% |
Operating margin | 5.70% |
Return on assets | 3.25% |
---|---|
Return on equity | 7.30% |
Return on investment | 7.08% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Henan Taloph Pharmaceutical Stock Co Ltd fell by 79.72m. However, the company earned 43.74m from its operations for a Cash Flow Margin of 2.11%. In addition the company generated 26.56m cash from financing while 150.02m was spent on investing.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.73 |
---|---|
Tangible book value per share | 2.09 |
More ▼
Balance sheet in CNYView more
Current ratio | 1.07 |
---|---|
Quick ratio | 0.81 |
Total debt/total equity | 0.7817 |
---|---|
Total debt/total capital | 0.4312 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items increased 159.11%.
Div yield(5 year avg) | 0.09% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 0.00% |
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 223.02 |
More ▼